Literature DB >> 8755575

Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury.

Z Y Yang1, R D Simari, N D Perkins, H San, D Gordon, G J Nabel, E G Nabel.   

Abstract

Arterial injury induces a series of proliferative, vasoactive, and inflammatory responses that lead to vascular proliferative diseases, including atherosclerosis and restenosis. Although several factors have been defined which stimulate this process in vivo, the role of specific cellular gene products in limiting this response is not well understood. The p21 cyclin-dependent kinase inhibitor affects cell cycle progression, senescence, and differentiation in transformed cells, but its expression in injured blood vessels has not been investigated. In this study, we report that p21 protein is induced in porcine arteries following balloon catheter injury and suggest that p21 is likely to play a role in limiting arterial cell proliferation in vivo. Vascular endothelial and smooth muscle cell growth was arrested through the ability of p21 to inhibit progression through the G1 phase of the cell cycle. Following injury to porcine arteries, p21 gene product was detected in the neointima and correlated inversely with the location and kinetics of intimal cell proliferation. Direct gene transfer of p21 using an adenoviral vector into balloon injured porcine arteries inhibited the development of intimal hyperplasia. Taken together, these findings suggest that p21, and possibly related cyclin-dependent kinase inhibitors, may normally regulate cellular proliferation following arterial injury, and strategies to increase its expression may prove therapeutically beneficial in vascular diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755575      PMCID: PMC38847          DOI: 10.1073/pnas.93.15.7905

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

2.  Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.

Authors:  M W Chang; T Ohno; D Gordon; M M Lu; G J Nabel; E G Nabel; J M Leiden
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

3.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

4.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

5.  Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models.

Authors:  R S Schwartz; W D Edwards; K R Bailey; A R Camrud; M A Jorgenson; D R Holmes
Journal:  Arterioscler Thromb       Date:  1994-03

6.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

8.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

Authors:  G J Nabel; E G Nabel; Z Y Yang; B A Fox; G E Plautz; X Gao; L Huang; S Shu; D Gordon; A E Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia.

Authors:  E G Nabel; L Shum; V J Pompili; Z Y Yang; H San; H B Shu; S Liptay; L Gold; D Gordon; R Derynck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  41 in total

1.  DNA replication and smooth muscle cell hypertrophy.

Authors:  K Walsh; I Shiojima; A Gualberto
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

Review 3.  Gene therapy for restenosis.

Authors:  R C Smith; K Walsh
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

4.  Phosphorylation regulates Id3 function in vascular smooth muscle cells.

Authors:  Scott T Forrest; Angela M Taylor; Ian J Sarembock; Demetra Perlegas; Coleen A McNamara
Journal:  Circ Res       Date:  2004-08-19       Impact factor: 17.367

5.  Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression.

Authors:  Michela Noseda; Linda Chang; Graeme McLean; Jonathan E Grim; Bruce E Clurman; Laura L Smith; Aly Karsan
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

6.  Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon.

Authors:  D Stephan; H San; Z Y Yang; D Gordon; S Goelz; G J Nabel; E G Nabel
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

Review 7.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

8.  Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3.

Authors:  Angela M Taylor; Feng Li; Pushpa Thimmalapura; Ross G Gerrity; Ian J Sarembock; Scott Forrest; Sarah Rutherford; Coleen A McNamara
Journal:  J Vasc Res       Date:  2005-12-07       Impact factor: 1.934

9.  Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.

Authors:  A M Sylvester; D Chen; K Krasinski; V Andrés
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

10.  NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis.

Authors:  Manjula Karpurapu; Dong Wang; Nikhlesh K Singh; Quanyi Li; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.